Although aerobic glycolysis’s role in cancer growth and metastasis remains poorly understood, CTD inhibits pyruvate kinase M2 (PKM2) nuclear translocation and disrupts the GLUT1/PKM2 glycolytic loop, promoting a shift from aerobic glycolysis to oxidation and subsequently reversing breast cancer metastasis (Pan et al., 2019). This evidence concerns the gene PKM and breast cancer.